Infectious disease
AstraZeneca’s COVID-19 vaccine road to approval has been anything but smooth.
A study found in India that the existing COVID-19 vaccines should be effective against the Indian variant, not just the Pfizer-BioNTech vaccine.
Battered by vaccine manufacturing mishaps that led to the contamination of 15 million doses of the Johnson & Johnson vaccine, Emergent BioSolutions is shaking up its leadership to ensure such errors do not occur again.
Asymptomatic individuals can transmit COVID-19. In fact, many cases worldwide are caused by people who are without symptoms.
Work-at-home arrangements created to respond to the COVID-19 pandemic have forced numerous companies in most sectors to reevaluate their work deals. This has also resulted in rethinking site locations and real estate needs. Here’s a look.
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
Moderna, one of three companies to have a COVID-19 vaccine authorized in the U.S., isn’t resting on its accomplishments but is instead working to scale up production further and improve on its vaccine.
Novartis AG Chief Executive Officer Vas Narasimhan believes that the hybrid of remote and on-site office work is the future.
According to Teo, the definition of the next pandemic depends a lot on one’s perspective.
As vaccinations against COVID-19 continue across the U.S., there appears to be an increase in cases in younger populations.
PRESS RELEASES